Clinical trial
Combination Chemotherapy in Treating Patients With Colorectal Cancer and…
NCT00268398 · GERCOR - Multidisciplinary Oncology Cooperative Group, Other · Completed
Key facts
| NCT number | NCT00268398 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases |
| Official title | Essai De Phase III De Chimiotherapie Par FOLFOX 4 Ou Par Une Succession FOLFOX 7 - FOLFIRI Chez Des Patients Ayant Des Metastases Resecables D'Origine Colorectale - MIROX |
| Acronym | MIROX |
| Lead sponsor | GERCOR - Multidisciplinary Oncology Cooperative Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer, Chemotherapy |
| Intervention type | Drug |
| Interventions | oxaliplatin, folinic acid, fluorouracil, irinotecan |
| Enrollment | 284 |
| Start date | Jul 1, 2002 |
| Primary completion | Dec 1, 2011 |
| First posted | Dec 22, 2005 |
| Last update posted | May 22, 2012 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: